Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Neuropsychiatric association of tirzepatide and semaglutide in obesity with and without type 2 diabetes
Communications medicine, 2026
[Insulin intoxications caused by falsified semaglutide]
Nederlands tijdschrift voor geneeskunde, 2026;170
Changes in food cravings, dietary quality, body composition, and dietary intake during GLP-1 receptor agonist therapy: The CRAVE study
Obesity pillars, 2026;19:100292
A Torilis japonica Extract-GHK-Cu Complex Attenuates Th2 Cytokines and Promotes Keratinocyte Recovery: A Potential Antioxidant Strategy for Atopic Dermatitis
Antioxidants (Basel, Switzerland), 2026;15(7)
Efficacy and Safety of Dual and Triple Glucagon-Like Peptide-1-Based Polyagonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis: A Systematic Review and Meta-Analysis
Cureus, 2026;18(6):e111728
Comparative Cardiovascular Outcomes and Safety Profiles of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Trials
Cureus, 2026;18(6):e111723
[The role of obesity and weight reduction in obstructive sleep apnea]
Orvosi hetilap, 2026;167(26):1011-1017
GLP-1 Receptor Agonists in Adolescents: Emerging Endocrine, Reproductive, and Psychosocial Concerns
Journal of pediatric and adolescent gynecology, 2026
Ease of Use, Ease of Learning, and Convenience of the CagriSema Dual-Chamber Pen: Results From a Usability Study in Adults With Overweight, Obesity, or Type 2 Diabetes
Journal of diabetes science and technology, 2026;:19322968261461530
GLP-1 Receptor Agonists and the Ocular Surface: A Narrative Review of Restoration, Remodeling, and Clinical Implications
Ophthalmology and therapy, 2026
Real-World Evidence of the Effectiveness and Safety of Biosynthetic Semaglutide in Type 2 Diabetes: A Multicentre Study From Pakistan
Diabetes, obesity & metabolism, 2026
GLP-1 receptor agonists in pediatric obesity and diabetes: a systematic review of efficacy, metabolic effects, and safety
Diabetes research and clinical practice, 2026;:113400
The silent rise of self-prescribed semaglutide use among non-obese young adults in the Middle East
Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2026;32(6):394-395
Beyond Weight Loss: Early Real-World Evidence of Semaglutide in Obesity
Medicines (Basel, Switzerland), 2026;13(3)
A Systematic Review and Meta-Analysis Evaluating the Role of GLP-1 Receptor Agonists in Substance Use Disorders
Cureus, 2026;18(6):e111641
Tirzepatide: A turning point in obesity related heart failure with preserved ejection fraction?
JPMA. The Journal of the Pakistan Medical Association;76(6):1001
GLP-1 receptor agonists and Risk of Cardiovascular and Pulmonary Complications in patients with OSA and Type 2 Diabetes Mellitus
Sleep & breathing = Schlaf & Atmung, 2026;30(4)
Chronic semaglutide alters ingestive behavior without impairing taste function in mice
Molecular metabolism, 2026;:102410
Secondary alopecia due to semaglutide
Medicina clinica, 2026;166(9):107507
Papular granuloma annulare associated with tirzepatide: A case report
JAAD case reports, 2026;74:225-227